You need Java to see this applet.
Our Mission

NanoPharmaceuticals.org is to foster and promote application of nanotechnology in the filed of
Pharmaceutical Science. This website is an honest attempt to give information about various
nanotechnologies, hot research publications, patents, news, companies etc. related to
NanoPharmaceuticals.  

Who We Are?
Web page Conceptualization and Design by:  
Dr. Kumaresh  S. Soppimath
Principal Scientist
Innopharma LLC
NJ, 08852
Scientific Advisory Board
Dr. Guru V. Betageri,
Professor and Chair
Department of Pharmaceutical Science
Collage of Pharmacy, Western University of Health Sciences
Pomona, CA, 91766, USA

Dr. Betageri obtained B.Pharm. from Karnatak University and M.Pharm. from Bangalore University. He
was awarded Ph.D. degree in Pharmaceutical Sciences from the University of Alberta, Edmonton,
Canada in 1987. Dr. Betageri joined National Cancer Institute as a visiting scientist at NIH, Bethesda,
MD. He accepted a faculty appointment at Auburn University in 1989 and was promoted to Associate
Professor in 1994. Dr. Betageri moved to Western University of Health Sciences in Pomona, California
in 1998. He was promoted to Full Professor and Chairman of the Department of Pharmaceutical
Sciences in 1999 and 2002 respectively. Dr. Betageri has advised eleven Ph.D. students and four M.S.
students. His areas of interest are drug delivery using lipids and liposomes. Recently his research group
is focusing on enhancement of dissolution and bioavailability using lipid based delivery system. He has
obtained grant support from Federal agencies as well as more than 25 Pharmaceutical companies to
support his research activities. Dr. Betageri has published more than 50 original research papers in
refereed journals and presented more than 100 papers at National and International meetings. He has
been invited speaker at various National and International Conferences and Pharmaceutical companies.
He serves as consultant to various pharmaceutical companies at US and International companies. He is
a reviewer for more than 12 pharmaceutical journals and he is also on the editorial board. He is a co-
author on the book entitled “Liposome Drug Delivery” and he has co-authored several book chapters.
He has been awarded three US patents on Pro-liposomal technologies. Dr. Betageri is an active member
at American Association of Pharmaceutical Scientists, American Association of Colleges of Pharmacy
and Controlled Release Society.
Dr. Jean-Christophe Leroux
Professeur agrégé / Associate professor
Canada Research Chair in Drug Delivery
Faculty of Pharmacy, University of Montreal
C.P. 6128 Succ. centre-ville
Montreal, Qc, H3C 3J7
Canada

Dr. Amiji received his undergraduate degree in pharmacy from Northeastern University in 1988 and his
PhD in pharmaceutics from Purdue University in 1992.  His areas of specialization include polymeric
biomaterials, advanced drug delivery systems, and nanomedical technologies.

Dr. Amiji’s research interests include synthesis of novel polymeric materials for medical and
pharmaceutical applications; surface modification of cationic polymers by the complexation-
interpenetration method to develop biocompatible materials; preparation and characterization of
polymeric membranes and microcapsules with controlled permeability properties for medical and
pharmaceutical applications; target-specific drug and vaccine delivery systems for gastrointestinal tract
infections; localized delivery of cytotoxic and antiangiogenic drugs for solid tumors in novel
biodegradable polymeric nanoparticles intracellular delivery systems for drugs and genes using target-
specific, long-circulating, biodegradable polymeric nanoparticles; gold and iron-gold core-shell
nanoparticles for biosensing, imaging and delivery applications.  His research has received sustained
funding from the National Institutes of Health, National Science Foundation, local industries, and
foundations.

Dr. Amiji is the Associate Chair of Pharmaceutical Sciences Department and Co-Director of
Northeastern University Nanomedicine Education and Research Consortium (NERC).  He has two
published books, Applied Physical Pharmacy and Polymeric Gene Delivery: Principles and Applications
along with numerous manuscript publications. He has also received a number of awards including the
2003 Eurand Award for Innovative Oral Drug Delivery Research.
Dr. S.M. MOGHIMI; BSc (Man.), PhD (Lond.)
Senior Lecturer
Molecular Targeting and Pharmaceutical Sciences
School of Pharmacy, University of Brighton
BN2 4GJ , UK
Moein Moghimi is a senior lecturer in at The School of Pharmacy, University of Brighton. Before
joining Brighton he was the University Research Fellow at the Department of Pharmaceutical Sciences,
University of Nottingham (UK). In the past 18 years, he has pioneered research in design and
engineering of nanoparticulate delivery vehiches for parenteral site-specific targeting and medical
imaging (splenotropic nanoparticles, lymphotropic agents and ‘phagocyte-resistant’ nanoparticles), and
more recently in nanotoxicology of synthetic gene transfer vectors and lipid-based nanocarriers (stealth
liposomes and lipid nanoparticles). He has published over 70 peer-reviewed original research papers and
invited critical reviews in leading international journals as well as over 80 book chapters, business
reports, editorials, and patents. Dr. Moghimi has served as invited theme editor for three issues of
Advanced Drug Delivery Reviews (1995, 2000, and 2006), one issue of Current Drug Delivery (2005),
and he is an editorial board member of the Journal of Liposome Research and Nanomedicine. He is also
on the scientific advisory panel of Nanopharmaceuticals.com and Multimedia Distributed Knowledge
Network in Nanotechnology-Nanopolis™ (France). In addition, Dr. Moghimi is actively a consultant to
over 30 pharmaceutical, biotechnology, health, and food industries world-wide as well as investment
banks, and has delivered more than 100 invited lectures in 20 countries. In 1985, he graduated in
biochemistry from The University of Manchester (UK) and in 1989 completed a PhD in liposomes
immunobiology at Charing Cross Hospital Medical School (Imperial College, University of London, UK).
About us | Advertising | Contact us
© 2005-2006 NanoPharmaceuticals.org. All rights reserved. No part of this Internet site may be
reproduced without prior written permission of the copyright holder. Terms & Disclaimer
About Us

Dr. Leroux is an associate professor at the Faculty of Pharmacy of the University of Montreal. He
received his B.Pharm. from the University of Montreal in 1992, followed by a Ph.D. in Pharmaceutical
Sciences (1996) from the University of Geneva (Switzerland). From 1996 to 1997 he completed a
postdoctoral training at the University of California, San Francisco and then joined the University of
Montreal as an assistant professor. He was promoted associate professor in 2002. Since September
2001, he is the holder of the Canada Research Chair in Drug Delivery. He supervises a group of 15
graduate students and postdoctoral fellows. His research interests include the design of novel
biopolymers, stimuli-responsive drug delivery systems (liposomes, micelles and gels) and the targeting
of anticancer drugs. He is the author or coauthor of more than 70 refereed articles, 8 book chapters
and 12 patents/patent applications. He serves in the editorial board of 6 journals including the Journal of
Controlled Release, the Journal of Pharmaceutical Sciences, the European Journal of Pharmaceutics
and Biopharmaceutics and the Journal of Drug Delivery Science and Technology. He has received the
Phoenix (1996), CRS-Capsugel (1997 and 2003), AFPC-Astra Zeneca (2003) and CRS young
investigator awards (2004) for innovative research in pharmaceutical technology. He also serves as a
consultant to various drug delivery companies.

Dr. Soppimath obtained both his bachelor and masters degree in pharmacy from Karnatak University.
He was awarded Ph.D. degree in Physical/Polymer Chemistry from Department of Chemistry Karnatak
University, India in 2001. Dr. Soppimath joined Sun Pharma Advance research Center, Baroda and later
joined Institute of Bio-Engineering and Nanotechnology, Singapore as Research Associate in 2002. He
is presently working as Research Scientist  with Dr. Betageri at Western University of Health Sciences
in Pomona, California. His areas of interest are formulation development, nano/microparticulate
systems, liposomes and Biomaterials. He has published more than 25 original research papers in
refereed journals and presented more than 15 papers at National and International meetings. His paper
on nanoparticles published in Journal of Controlled Release was listed as one of the top25 highly
downloaded articles. His research finding on core shell nanoparticles, for which he has a US patent
pending, was highlighted by Nanotech News, published by National Cancer Institute and  NanoBiotech
News. Dr. Soppimath is an active member at American Association of Pharmaceutical Scientists and
Controlled Release Society.
Dr. Mansoor M. Amiji,
Associate Professor of Pharmaceutical Sciences
Associate Chair, Department of Pharmaceutical Sciences
Co-Director of Northeastern University Nanomedicine Education and
Research Consortium (NERC)
Boston, MA 02115 USA